Skip to main content
EMA Logo
  • Medicines
    Medicines

    • Search
    • Download
    • What we publish and when
    • Medicines under evaluation
    • National registers
  • Human regulatory
    Human regulatory

    • Overview
    • Research and development
    • Marketing authorisation
    • Post-authorisation
    • Herbal products
  • Veterinary regulatory
    Veterinary regulatory

    • Overview
    • Research and development
    • Marketing authorisation
    • Post-authorisation
  • Committees
    Committees

    • How the committees work
    • CHMP
    • CVMP
    • PRAC
    • COMP
    • HMPC
    • CAT
    • PDCO
    • Working parties and other groups
  • News & events
    News & events

    • News and press releases
    • Events
    • What's new
    • Committee highlights
    • Therapeutic areas: latest updates
    • Publications
    • Press and social media
    • Open consultations
    • RSS feeds
  • Partners & networks
    Partners & networks

    • EU partners
    • International activities
    • Patients and consumers
    • Healthcare professionals
    • Academia
    • Pharmaceutical industry
    • Networks
    • Health technology assessment bodies
  • About us
    About us

    • What we do
    • Who we are
    • How we work
    • Annual reports and work programmes
    • History of EMA
    • Careers
    • Procurement
    • Glossaries
    • About this website
    • Data protection and privacy
    • FAQs
    • Contacts

COVID-19

All info here

QUICK LINKS

  • Latest updates
  • Vaccines
  • Treatments
  • Guidance for developers and companies
  • Management Board: Highlights of June 2023 meeting
    Management Board meeting highlights
    Management Board |Highlights

    Management Board: Highlights of June 2023 meeting

  • Management Board: Highlights of June 2023 meeting
    Management Board meeting highlights
    Management Board |Highlights

    Management Board: Highlights of June 2023 meeting

    The Board adopted the Executive Director’s annual activity report for 2022 and was updated on recent initiatives on clinical trials in the EU

  • Highlights of the Safety Committee: June 2023
    PRAC highlights October 2021
    MEDICINES |COMMITTEES

    Highlights of the Safety Committee: June 2023

  • Highlights of the Safety Committee: June 2023
    PRAC highlights October 2021
    MEDICINES |COMMITTEES

    Highlights of the Safety Committee: June 2023

    At its monthly meeting, EMA's safety committee, the PRAC, carried out its work to assess all aspects of risk management related to the use of medicines

  • EMA-ECDC updates on adapted COVID-19 vaccines
    EMA and ECDC joint statement
    COVID-19 |vaccines

    EMA-ECDC updates on adapted COVID-19 vaccines

  • EMA-ECDC updates on adapted COVID-19 vaccines
    EMA and ECDC joint statement
    COVID-19 |vaccines

    EMA-ECDC updates on adapted COVID-19 vaccines

    The European Centre for Disease Prevention and Control (ECDC) and EMA have issued a joint statement on adapted COVID-19 vaccines and their use in autumn vaccination campaigns

  • Adapting COVID-19 vaccines to future variants
    Future changes to COVID-19 vaccines
    COVID-19 |International collaboration

    Adapting COVID-19 vaccines to future variants

  • Adapting COVID-19 vaccines to future variants
    Future changes to COVID-19 vaccines
    COVID-19 |International collaboration

    Adapting COVID-19 vaccines to future variants

    Global regulators agreed on a way forward to adapt COVID-19 vaccines to future variants, during a workshop co-chaired by EMA and the FDA, under the umbrella of ICMRA

Search for medicines
Search for information on human, veterinary or herbal medicines.
What's new
Find all the latest news and updates published on this website in one place.
FAQs
Find answers to the most frequently asked questions we receive.

Latest news

  • List item
    09/06/2023

    EMA Management Board: highlights of June 2023 meeting

    EMA’s Management Board met on 7-8 June in Amsterdam. The European Commission informed the Board about its legal proposals to revise the pharmaceutical legislation, published on 26 April, which aim to make the EU regulatory framework fit for...

  • List item
    09/06/2023

    Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5 - 8 June 2023

    At its monthly meeting, EMA’s safety committee (PRAC) carried out its broad range of responsibilities, which cover all aspects of the risk management of the use of medicines: assessment of safety signals, risk management plans, periodic safety...

  • List item
    06/06/2023 COVID-19

    EMA and ECDC statement on updating COVID-19 vaccines to target new SARS-CoV-2 virus variants

    The European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) have issued a joint statement on adapted COVID-19 vaccines and considerations for their use during the upcoming autumn 2023 vaccination campaigns...

  • List item
    31/05/2023

    Progress with EU-US mutual recognition agreement for inspections for veterinary medicines

    Today, the European Union (EU) and the United States (US) have made important progress towards enabling mutual recognition of inspections of manufacturing facilities of certain veterinary products. The Food and Drug Administration (FDA) has...

  • List item
    30/05/2023 COVID-19

    Global regulators agree on way forward to adapt COVID-19 vaccines to emerging variants

    International regulators have published a report today highlighting the outcomes of their discussions on COVID-19 vaccines and the need for and strategy to update their composition based on the emerging evidence on coronavirus SARS-CoV-2 variants...

  • List item
    26/05/2023

    EMA business hours over Whit Monday, 29 May

    The European Medicines Agency's (EMA) office is closed on Monday 29 May 2023. Outside of working hours and on public holidays, it is possible to call the product emergency hotline on +31(0)88 781 7600. Please note that this is an emergency number...

  • Load more news

Information for you

Patients and carers
Featured news and updates for patients and carers
Healthcare professionals
Featured news and updates for healthcare professionals, including doctors, nurses and pharmacists
Animal health professionals
Featured news and updates for animal health professionals and users of veterinary medicines such as pet owners
Pharmaceutical industry
Featured news and updates for pharmaceutical industry stakeholders active in the human and veterinary medicines fields
Media
Featured news and updates for journalists with a professional interest in the development and availability of medicines in the European Union
Academia
Featured news and updates for European academics and researchers in the field of medicine development

Key content

  • List item

    Product emergency hotline

  • List item

    UK’s withdrawal from the EU

  • List item

    PRIME: Priority medicines

  • List item

    Pharmacovigilance (safety monitoring)

  • List item

    Data on medicines

  • List item

    Clinical data publication

  • List item

    Careers

Services & databases

  • List item

    Clinical Trials website

  • List item

    Account Management portal

  • List item

    eSubmission

  • List item

    EudraVigilance (human)

  • List item

    EudraVigilance Veterinary

  • List item

    Veterinary Medicines information website

  • List item

    Suspected adverse drug reactions database

  • List item

    Clinical data

  • List item

    SPOR data management services

  • List item

    Service Desk

  • List item

    IRIS platform

  • List item

    Public register of parallel distribution notices

  • List item

    European Vaccination Information Portal

How does EMA work?

  • List item

    What we do

  • List item

    Our role in authorisation of medicines

  • List item

    Who we are

  • List item

    Our scientific experts

  • List item

    How we work

  • List item

    What we publish

Product emergency hotline
outside working hours
  • About us
  • What we do
  • Careers
  • Committees
  • Regulatory network
  • Languages
  • Frequently asked questions
  • Glossaries
  • About this website
  • Privacy
  • Search tips
  • Access to documents
  • Contacts
  • Send a question
  • EMA Service desk (system support)

European Medicines Agency
Domenico Scarlattilaan 6
1083 HS Amsterdam
The Netherlands

Tel: +31 (0)88 781 6000

How to find us

Postal address and deliveries

Business hours and holidays

For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.
RSS feed Twitter YouTube LinkedIn
© 1995-2023 European Medicines Agency
European Union agencies network
European Union agencies network
An agency of the European Union
European Union flag